Mbarara University of Science and Technology
Mbarara, Uganda
NCT Number: NCT06969677
Randomized trial to measure the effect of personalized normative feedback about local HIV testing rates and local rates of HIV-related stigma on self-reported HIV testing intentions and perceptions about others' HIV testing intentions.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Mbarara, Uganda
HIV testing is a vital step in identifying and treating HIV. Research in rural Uganda reveals underestimation of community HIV testing rates and overestimation of HIV-related stigma among adults. At the same time, perceived norms (i.e., estimated rates regardless of their accuracy) are associated with personal HIV testing behavior and personal HIV-related attitudes.
This study employs a randomized controlled trial to evaluate how providing accurate information about local descriptive (i.e., behavioral) norms and local injunctive (i.e., attitudinal) norms affect HIV testing intentions. Participants are randomly assigned to one of four treatment arms: (1) they are reminded of what they thought community testing rates were in their village and then receive accurate information about high community testing rates, (2) they are reminded of what they thought local stigma rates were in their village and then receive accurate information about positive community perceptions of persons with HIV, (3) they are reminded of what they thought community testing rates and local stigma rates were in their village and then receive both types of accurate normative information, or (4) they are reminded of what they thought community testing rates were in their village and receive no further information (control group).
The study assesses how providing this type of personalized normative feedback within cohort-based data collection affects personal reports about getting tested for HIV in the next 12 months and how it affects perceptions about how many men and women in the same village will get tested for HIV in the next 12 months. It is hypothesized that providing accurate information about local community testing rates and/or attitudes toward persons with HIV will increase reported personal willingness to get tested (primary outcome) and improve the accuracy of estimated community testing rates in the future (secondary outcome).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Each version of the questionnaire has similar questions about personal HIV testing intentions and perceived norms about other men and women's HIV testing intentions. The content of the prompt presented prior to the questions varies based on treatment arm.
This version does not provide any normative feedback information.
Time frame: Baseline (assessed at the time the survey is administered)
Regarding yourself, how likely are you to go get tested for HIV in the next 12 months? (single item)
Time frame: Baseline (assessed at the time the survey is administered)
How many of these men do you think will go get tested for HIV in the next 12 months? (single item)
Time frame: Baseline (assessed at the time the survey is administered)
How many of these women do you think will go get tested for HIV in the next 12 months? Read all response options audibly, except for refuses/do not know.
(single item)
Massachusetts General Hospital
Other
Personalized Normative Feedback to Increase HIV Testing Among Adults in Rural Uganda
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07074899
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Lima, Lima Province, Peru
View Trial DetailsNCT05306938
Behavior, Contraception Behavior
Dar es Salaam, Tanzania
View Trial DetailsNCT07165496
Behavior, HIV Testing
Lima, Lima Province, Peru
View Trial DetailsNCT05615935
Acquired Immunodeficiency Syndrome, Behavior
Taipei, Taiwan
View Trial Details